Server:Oscar Platform 20180...
The main IP address: 96.45.83.224,Your server United States,Reston ISP:Tiggee LLC TLD:com CountryCode:US
The description :
cancer cell international publishes articles on all aspects of cancer cell biology. the journal focuses on cancer studies reporting data from biological experiments perform... This report updates in 23-Jun-2018
Technical data of the cancerci.comGeo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host cancerci.com. Currently, hosted in United States and its service provider is Tiggee LLC .
the related websites
HTTP Header AnalysisHTTP Header information is a part of HTTP protocol that a user's browser sends to called Oscar Platform 201802052158-170 containing the details of what the browser wants and will accept back from the web server.
DNS
HtmlToTextskip to content advertisement menu explore journals get published about bmc login my account search search all bmc articles search cancer cell international menu home about articles submission guidelines search submit a manuscript call for papers: emerging biomarkers in oncology research and practice we are pleased to announce cancer cell international is now accepting submissions for a thematic series on 'emerging biomarkers in oncology research and practice'. guest edited by dr aejaz nasir, the series aims to cover cutting-edge developments in the field of oncology and pathology with reference to diagnostic, prognostic, predictive and pharmacodynamics biomarkers. read more articles recent most accessed content type: primary research | 22 june 2018 the association of semaphorin 5a with lymph node metastasis and adverse prognosis in cervical cancer authors: jian-bing xiao, xin-lei li, le liu, geng wang, song-nan hao, hui-juan dong, xue-min wang, ya-fang zhang and hui-dong liu content type: primary research | 19 june 2018 ets1 is associated with cisplatin resistance through ikkα/nf-κb pathway in cell line mda-mb-231 authors: yuzhu zhang, jingjing wu, meina ye, bing wang, jiayu sheng, bailing shi and hongfeng chen content type: review | 18 june 2018 targeting dendritic cells in pancreatic ductal adenocarcinoma authors: anton deicher, roland andersson, bobby tingstedt, gert lindell, monika bauden and daniel ansari content type: primary research | 14 june 2018 interferon-γ and smac mimetics synergize to induce apoptosis of lung cancer cells in a tnfα-independent manner authors: qin hao and hua tang content type: primary research | 8 june 2018 mir-218 regulates epithelial–mesenchymal transition and angiogenesis in colorectal cancer via targeting ctgf authors: weijian lun, xiongjian wu, qiliang deng and fachao zhi most recent articles rss view all articles content type: review | 3 september 2013 acidic extracellular microenvironment and cancer authors: yasumasa kato, shigeyuki ozawa, chihiro miyamoto, yojiro maehata, atsuko suzuki, toyonobu maeda and yuh baba content type: review | 28 january 2015 understanding the colon cancer stem cells and perspectives on treatment authors: elsa n garza-treviño, salvador l said-fernández and herminia g martínez-rodríguez content type: review | 4 june 2007 role of stem cells in cancer therapy and cancer stem cells: a review authors: jayesh sagar, boussad chaib, kevin sales, marc winslet and alexander seifalian content type: primary research | 21 april 2015 b7-h3 promotes aggression and invasion of hepatocellular carcinoma by targeting epithelial-to-mesenchymal transition via jak2/stat3/slug signaling pathway authors: fu-biao kang, ling wang, heng-chuan jia, dong li, hai-jun li, yin-ge zhang and dian-xing sun content type: primary research | 4 february 2015 treatment with the parp inhibitor, niraparib, sensitizes colorectal cancer cell lines to irinotecan regardless of msi/mss status authors: sybil m genther williams, apryle m kuznicki, paula andrade, brian m dolinski, cem elbi, ronan c o’hagan and carlo toniatti most accessed articles rss view all articles editors' pick: inhibition of the pi3k but not the mek/erk pathway sensitizes human glioma cells to alkylating drugs aims and scope cancer cell international publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. read more editors-in-chief y eugene chin, shanghai institute of biological sciences, china domenico coppola, moffitt cancer center, usa associate editor spotlight mariano bizzarri dr mariano bizzarri is associate professor of clinical pathology in the department of experimental medicine at university sapienza, rome, and head of the interdepartmental systems biology center (sbglab). he is a cancer researcher with expertise in the study of systems biology approach in the integrative understanding of cell and tumor biology, namely by focusing on cell phenotypic transition, tumor reversion and cell-microenvironment cross-talk. editorial board spotlight zhenhua zou dr zhenhua zou is a research fellow at the university of michigan medical school, where she studies epigenetic mechanisms in leukemia and retinoblastoma. she received her doctoral degree in cell biology from the institute of genetics and developmental biology, chinese academy of sciences. with long-term focus and interest in cancer areas, she has accumulated expertise in epigenetics, drug target discoveries, and dysfunctional metabolic and immune signaling in cancer stem cells. advertisement submit a manuscript editorial board sign up for article alerts and news from this journal 2016 journal metrics speed 30 days from submission to first decision 11 days from acceptance to publication citation impact 2.740 - 2-year impact factor 2.924 - 5-year impact factor 0.897 - source normalized impact per paper (snip) 1.006 - scimago journal rank (sjr) usage 327,909 downloads 950.0 usage factor social media impact 73 mentions more about our metrics advertisement cancer cell international issn: 1475-2867 contact us submission enquiries: [email protected] general enquiries: [email protected] explore journals get published about bmc read more on our blogs receive bmc newsletters manage article alerts language editing for authors scientific editing for authors policies accessibility press center contact us leave feedback careers follow bmc bmc twitter page bmc facebook page bmc google plus page bmc weibo page by using this website, you agree to our terms and conditions , privacy statement and cookies policy. manage the cookies we use in the preference centre. © 2018 biomed central ltd unless otherwise stated. part of springer nature . URL analysis for cancerci.com
https://cancerci.biomedcentral.com/articles Whois InformationWhois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;
Domain Name: CANCERCI.COM MistakesThe following list shows you to spelling mistakes possible of the internet users for the website searched .
|